TXG
10x Genomics·NASDAQ
--
--(--)
--
--(--)
3.95 / 10
Netural
Analyst sentiment is neutral, with both TD Cowen and Leerink Partners maintaining Neutral ratings and zero historical win rates. Fund flow is positive, scoring 7.9/10, with block and extra-large inflows indicating institutional interest. The overall fund flow trend is positive, which may support price stabilization despite technical weakness. The combination of neutral analyst views and improving money flow underscores the need for vigilance and further technical confirmation.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-07
InstitutionTD Cowen
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for TXG?
- TXG holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.95/10 (Netural).
